Published: Guidance, quality standards and advice
Showing 11 to 15 of 15
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Velmanase alfa for treating alpha-mannosidosis | HST29 | ||
| Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer | TA939 | ||
| Acne vulgaris: management | NG198 | ||
| Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal) | TA938 | ||
| Secukinumab for treating moderate to severe hidradenitis suppurativa | TA935 |